This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
Genomic Biomarker Testing
PEACE-3 Trial
PROfound Trial
PSMAfore Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
BOND-003 Cohort P
CORE-001 Study
CORE-008
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Daniel D. Joyce, MD, MS
Bladder Cancer
Non-Muscle Invasive Bladder Cancer
Ashish Kamat, MD
Muscle-Invasive Bladder Cancer
Advanced & Metastatic Bladder Cancer (mUC)
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher® Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
mCRPC with Bone Metastasis
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
Testicular, Penile & Rare GU Malignances
Testicular Cancer
Functional Urology
Functional Urology
Alan J. Wein, MD, PhD (hon.)
Urologic Catheters - CAUTI Challenges
Videos
Exclusives
Conferences
Disparities: Social Determinants of Health
Exclusive Collaborations
Health Policy in Urological Diseases
Independent Medical Education
Journal Clubs
Practice Guidelines Reviews
The Prostate Cancer Foundation
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Functional Urology
Men's Health
Pelvic Health
Actionable Clinical Data
Bladder Cancer
NMIBC with CIS: Evidence, Practice & Emerging Research
Risk-Stratified NMIBC Management
Trials in Progress
Prostate Cancer
Localized Prostate Cancer
CLARIFY
ESCAPE
FORT
NRG-GU 0101
RTIRE
High Risk BCR HSPC
ARASTEP
Oligometastatic Prostate Cancer
METANOVA
mHSPC
ARASEC
ASPIRE
MEVPRO-3
mCRPC
ECLIPSE
LEGION-100
MEVPRO-1 & 2
PROMISE
SECuRE
Bladder Cancer
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SNMMI 2026
ASCO 2026
AUA 2026
APCCC 2026
PSMA and Beyond 2026
All Conferences
View All
PCF
UroToday Home
Conference Highlights
EAU 2020
EAU 2020
Prostate Cancer
Bladder Cancer
Kidney Cancer
Testicular and Penile Cancer
Press Releases
EAU 2020 Prostate Cancer
Viewing 1-20 of 48 articles
EAU 2020: Treatment of Recurrent Lymph Node Metastatic Prostate Cancer - Radiation Is the Best Option
EAU 2020: Recognising Images, Tissues, Signals
EAU 2020: The Real Effect of Prostate Cancer Treatment: EUPROMS First-Ever Prostate Patient-Driven Quality of Life Study
EAU 2020: Salvage Lymph Node Dissection in Prostate Cancer: Primary Treatment of Pelvic Lymph Node Metastatic Prostate Cancer - Systemic Only
EAU 2020: What Are the Consequences for Implants in Urology with the New EU Directive?
EAU 2020: Five Things I Wish I Would Have Known Earlier in My Career: Lessons from the Mentors - Prostate Cancer
EAU 2020: New Technology for Urology: 7T MRI Scanner
EAU 2020: Imagine All the People… Is There a Second, Digital, Me?
EAU 2020: Salvage Lymph Node Dissection in Prostate Cancer: Does Early Diagnosis Help the Patient?
EAU 2020 Treatment of Recurrent Lymph Node Metastatic Prostate Cancer - Surgery Is the Best Option
EAU 2020: Primary Treatment of Pelvic Lymph Node Metastatic Prostate Cancer - Surgery Only
EAU 2020: Primary Treatment of Pelvic Lymph Node Metastatic Prostate Cancer - Radiation Only
EAU 2020: A Prospective, Open, Multicentre, Phase II Clinical Trial of Bicalutamide Alone or With Addition of Docetaxel in Nonmetastatic Prostate Cancer With a Rising PSA (SPCG-14)
EAU 2020: Midterm Oncological Results of Focal Therapy: HIFU Focal Ablation
EAU 2020: Treatment of Polymetastatic Hormone Sensitive Prostate Cancer
EAU 2020: Late Toxicity and Quality of Life from GETUG-AFU 22 Study: A Randomised Phase II Trial Comparing 6 Months of Degarelix in Combination with Radiotherapy to Radiotherapy Alone for Patients with Detectable PSA After Radical Prostatectomy
EAU 2020: Case-based Debate PSMA-targeted Radioligand Therapy: Which Patients, Which Stages? Treatment Options: Medical oncologist, Nuclear medicine, and Urologist Perspectives
EAU 2020: Imaging of Castrate-resistant Prostate Cancer - What is Possible, What is Necessary
EAU 2020: What Should You Do with Men You Do Not Biopsy, or Whose Biopsy Is Negative?
EAU 2020: Limitations of PSMA Based on Prostate Cancer Biology
1
2
3
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free